Paid Clinical Trials in Abilene, TX
As of September 2026, 49 paid clinical trials are recruiting in Abilene, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Abilene offers studies at sites including Hendrick Medical Center for conditions such as Colorectal Neoplasms, Non-small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer, Age-Related Macular Degeneration. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Abilene
Trials by drug in Abilene
Filter results
46 clinical trials
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
SELUTION 4 De Novo Small Vessel IDE Trial
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Evaluation of the Bexa Breast Examination
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Top Research Study Locations in Abilene
Researchers run research studies in Abilene, TX at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Hendrick Medical Center | Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | 8 |
| Retina Research Institute of Texas | Macular Edema Secondary to Inflammation, Age-related Macular Degeneration (AMD), Diabetic Macular Edema | 8 |
| Texas Oncology - West Texas | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 6 |
| Hendrick Health | Heart Failure, Coronary Artery Disease, Diabetes Mellitus, Type 2 | 5 |
| Texas Oncology - Abilene - Antilley Road | Hepatocellular Carcinoma, Ovarian Cancer, Colorectal Cancer | 3 |
| Texas Oncology West Texas | Colorectal Neoplasms | 2 |
| ACT-Midwest G1 | Ulcerative Colitis | 1 |
| Abilene Ctr For Ortho and Multi | Lumbar Spinal Stenosis | 1 |
| Abilene Spine and Joint Surgery Center | Lumbar Spinal Stenosis | 1 |
| Abilene, Texas | Branch Retinal Vein Occlusion (BRVO), Neovascular Age-Related Macular Degeneration (NVAMD) | 1 |
| Advance Clinical Trial PLLC | Irritable Bowel Syndrome With Constipation (IBS-C) | 1 |
| Area Agency on Aging of West Central Texas; Northwest District APS | Elder Abuse, Self-Neglect | 1 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| Hendrick Cancer Center | Breast Cancer | 1 |
| Hendrick Health - Vera West Women's Center | Breast Cancer | 1 |
| Hendrick Health System | Extensive Stage Small Cell Lung Cancer (ES-SCLC) | 1 |
| Hendrick Med Ctr South | Lumbar Spinal Stenosis | 1 |
| Local Institution - 007-554B | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Retina Consultants of Texas - Abilene (01035) | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Retina Research Institute of Texas | Age-Related Macular Degeneration, Geographic Atrophy | 1 |
| Texas Oncology - West (SCRI) | Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer | 1 |
| Texas Oncology, P.A. - Abilene - 300210366 | Metastatic Colorectal Cancer | 1 |
| Texas Oncology-Abilene | Ovarian Cancer | 1 |
| USOR Texas Oncology | Breast Adenocarcinoma, Endometrial Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC) | 1 |
Active & Upcoming Studies in Abilene (2026)
Recruiting trials in Abilene grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (24 active studies)
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · Phase 3 · Immuneering Corporation
- A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer · Phase 3 · AbbVie
Eye & vision (11 active studies)
- A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) · Phase 1 · Genentech, Inc.
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
Cardiovascular (3 active studies)
- Alleviant ALLAY-HFrEF Study · Alleviant Medical, Inc.
- SELUTION 4 De Novo Small Vessel IDE Trial · M.A. Med Alliance S.A.
Mental health & behavior (1 active study)
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Diabetes & metabolic (1 active study)
Common conditions studied in Abilene
- Colorectal Neoplasms (3 active studies)
- Non-small Cell Lung Cancer (3 active studies)
- Advanced Non-Small Cell Lung Cancer (2 active studies)
- Age-Related Macular Degeneration (2 active studies)
- Breast Cancer (2 active studies)
- Breast Neoplasms (2 active studies)
Leading research sponsors in Abilene
- AbbVie
- Pfizer
- Alleviant Medical, Inc.
- Alliance for Clinical Trials in Oncology
- Bristol-Myers Squibb
Frequently asked questions
How many paid clinical trials are currently recruiting in Abilene?
There are approximately 49 recruiting clinical trials in Abilene, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Abilene pay participants?
Most recruiting trials in Abilene compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Abilene?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Abilene?
The most common conditions under active study in Abilene include Colorectal Neoplasms (3), Non-small Cell Lung Cancer (3), Advanced Non-Small Cell Lung Cancer (2), Age-Related Macular Degeneration (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Abilene?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Abilene on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Abilene?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Abilene?
Recruiting research sites in Abilene include Hendrick Medical Center, Retina Research Institute of Texas, Texas Oncology - West Texas, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Abilene right now?
The largest active categories in Abilene are Cancer & tumors (24), Eye & vision (11), Cardiovascular (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.